68ga-nota-ae105
Small moleculeexperimentalImaging agent
Clinical trial activity
12 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
10
Phase 3
0
Phase 4
0
Earliest trial started May 31, 2014 (NCT02139371)
Timeline
Indications
Studied for
- Breast Neoplasms · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Glioblastoma · Phase 2
- Head and Neck Neoplasms · Phase 2
- Lung Neoplasms · Phase 2
- Mesothelioma, Malignant · Phase 2
- Mouth Neoplasms · Phase 2
- Neoplasm Metastasis · Phase 2
- Neoplasms · Phase 2
- Neoplasms by Site · Phase 2
- Neuroendocrine Tumors · Phase 2
- Oropharyngeal Neoplasms · Phase 2
- Prostatic Neoplasms · Phase 2
- Urinary Bladder Neoplasms · Phase 2
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Also known as
- 68ga-nota-ae105
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06474806 | Phase 2 | Jun 1, 2024 | ABX-CRO, Curasight |
| NCT03307460 | Phase 2 | Nov 21, 2017 | University of Copenhagen |
| NCT03278275 | Phase 2 | Nov 20, 2017 | University of Copenhagen |
| NCT02964988 | Phase 2 | Jan 1, 2017 | University of Copenhagen |
| NCT02945826 | Phase 2 | Jan 1, 2017 | University of Copenhagen |
| NCT02960724 | Phase 2 | Nov 30, 2016 | University of Copenhagen |
| NCT02965001 | Phase 2 | Nov 1, 2016 | University of Copenhagen |
| NCT02805608 | Phase 2 | Sep 1, 2016 | University of Copenhagen |
| NCT02755675 | Phase 2 | Apr 30, 2016 | University of Copenhagen |
| NCT02681640 | Phase 2 | Mar 31, 2016 | University of Copenhagen |
| NCT02437539 | Phase 1 | May 1, 2015 | Curasight, University of Copenhagen |
| NCT02139371 | Early Phase 1 (Phase 1) | May 31, 2014 | University of Copenhagen |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Copenhagen | Academic/Hospital | 11 | 11 | 2 | 2014 |
| Curasight | For profit | 2 | 1 | 2 | 2015 |
| ABX-CRO | For profit | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1